Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 20546255)

1.

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.

Gerich JE.

Diabet Med. 2010 Feb;27(2):136-42. doi: 10.1111/j.1464-5491.2009.02894.x. Review.

2.

Kidney: its impact on glucose homeostasis and hormonal regulation.

Mitrakou A.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S66-72. doi: 10.1016/S0168-8227(11)70016-X. Review.

PMID:
21864754
3.

Glucose handling by the kidney.

Mather A, Pollock C.

Kidney Int Suppl. 2011 Mar;(120):S1-6. doi: 10.1038/ki.2010.509. Review.

4.
5.

Understanding the kidneys' role in blood glucose regulation.

Triplitt CL.

Am J Manag Care. 2012 Jan;18(1 Suppl):S11-6. Review.

6.

[Contribution of the kidney to glucose homeostasis].

Segura J, Ruilope LM.

Med Clin (Barc). 2013 Sep;141 Suppl 2:26-30. doi: 10.1016/S0025-7753(13)70060-5. Review. Spanish.

PMID:
24444521
7.

Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus.

Neumiller JJ, White JR Jr, Campbell RK.

Drugs. 2010 Mar 5;70(4):377-85. doi: 10.2165/11318680-000000000-00000. Review.

PMID:
20205482
8.

A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition.

Basile J.

Postgrad Med. 2011 Jul;123(4):38-45. doi: 10.3810/pgm.2011.07.2302. Review.

PMID:
21680987
9.

Glucose control by the kidney: an emerging target in diabetes.

Marsenic O.

Am J Kidney Dis. 2009 May;53(5):875-83. doi: 10.1053/j.ajkd.2008.12.031. Epub 2009 Mar 26. Review.

PMID:
19324482
10.

Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.

Meyer C, Woerle HJ, Dostou JM, Welle SL, Gerich JE.

Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1049-56. Epub 2004 Aug 10.

11.

Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus.

Chen LH, Leung PS.

Diabetes Obes Metab. 2013 May;15(5):392-402. doi: 10.1111/dom.12064. Epub 2013 Feb 6. Review.

PMID:
23331516
12.

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.

DeFronzo RA, Davidson JA, Del Prato S.

Diabetes Obes Metab. 2012 Jan;14(1):5-14. doi: 10.1111/j.1463-1326.2011.01511.x. Review.

PMID:
21955459
13.

Renal glucose reabsorption inhibitors to treat diabetes.

Bailey CJ.

Trends Pharmacol Sci. 2011 Feb;32(2):63-71. doi: 10.1016/j.tips.2010.11.011. Epub 2011 Jan 4. Review.

PMID:
21211857
14.

[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].

Pérez López G, González Albarrán O, Cano Megías M.

Nefrologia. 2010;30(6):618-25. doi: 10.3265/Nefrologia.pre2010.Sep.10494. Review. Spanish.

15.

The role of the kidney in hyperglycemia: a new therapeutic target in type 2 diabetes mellitus.

Hinnen D.

J Cardiovasc Nurs. 2013 Mar-Apr;28(2):157-65. doi: 10.1097/JCN.0b013e318245633e.

PMID:
22343215
16.

Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

Vallon V, Rose M, Gerasimova M, Satriano J, Platt KA, Koepsell H, Cunard R, Sharma K, Thomson SC, Rieg T.

Am J Physiol Renal Physiol. 2013 Jan 15;304(2):F156-67. doi: 10.1152/ajprenal.00409.2012. Epub 2012 Nov 14.

17.

The role of kidney in glucose homeostasis--SGLT2 inhibitors, a new approach in diabetes treatment.

Andrianesis V, Doupis J.

Expert Rev Clin Pharmacol. 2013 Sep;6(5):519-39. doi: 10.1586/17512433.2013.827399. Epub 2013 Aug 26. Review.

PMID:
23978089
18.

The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.

Vallon V.

Annu Rev Med. 2015;66:255-70. doi: 10.1146/annurev-med-051013-110046. Epub 2014 Oct 17.

PMID:
25341005
19.

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Bakris GL, Fonseca VA, Sharma K, Wright EM.

Kidney Int. 2009 Jun;75(12):1272-7. doi: 10.1038/ki.2009.87. Epub 2009 Apr 8. Review.

PMID:
19357717
20.

Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.

Jabbour SA, Whaley JM, Tirmenstein M, Poucher SM, Reilly TP, Boulton DW, Saye J, List JF, Parikh S.

Postgrad Med. 2012 Jul;124(4):62-73. doi: 10.3810/pgm.2012.07.2569. Review.

PMID:
22913895
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk